---
title: "关键事实：Hims & Hers Health 的股价下跌 14.1%；美国食品药品监督管理局（FDA）限制减肥药的使用"
description: "Hims & Hers Health 的股价下跌了 14.1%，至 19.76 美元，此前 FDA 限制了其 49 美元减肥药的销售，并将该公司移交给司法部以调查可能的违规行为。FDA 警告 Hims & Hers Health 不得将未获批准的产品称为已批准药物的仿制药，并表示将使用所有执法手段来应对虚假声明"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/275210139.md"
published_at: "2026-02-07T20:03:01.000Z"
---

# 关键事实：Hims & Hers Health 的股价下跌 14.1%；美国食品药品监督管理局（FDA）限制减肥药的使用

> Hims & Hers Health 的股价下跌了 14.1%，至 19.76 美元，此前 FDA 限制了其 49 美元减肥药的销售，并将该公司移交给司法部以调查可能的违规行为。FDA 警告 Hims & Hers Health 不得将未获批准的产品称为已批准药物的仿制药，并表示将使用所有执法手段来应对虚假声明

-   Hims & Hers Health 的股票下跌了 14.1%，至 19.76 美元，此前 FDA 限制了其 49 美元减肥药的销售，并将该公司移交给司法部以调查可能的违规行为。1
-   FDA 警告 Hims & Hers Health 不得将未获批准的产品称为已批准药物的仿制药，表示将使用所有执法工具来处理虚假声明。2

### Related Stocks

- [HIMS.US - Hims & Hers Health](https://longbridge.com/zh-CN/quote/HIMS.US.md)
- [HIMY.US - Defiance Leveraged Long +Income HIMS ETF](https://longbridge.com/zh-CN/quote/HIMY.US.md)
- [HIMZ.US - 2 倍做多 HIMS ETF - Defiance](https://longbridge.com/zh-CN/quote/HIMZ.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| ANALYSIS-US could take action including fines against Hims after brief Wegovy copy launch | The Trump administration may take legal action against Hims for attempting to sell a compounded version of Novo Nordisk' | [Link](https://longbridge.com/zh-CN/news/276042978.md) |
| Hims & Hers Tumbles Another 10% As Legal Liability Mounts | Hims & Hers Health (HIMS) saw its stock drop another 10% following regulatory issues related to its compounded GLP-1 wei | [Link](https://longbridge.com/zh-CN/news/275653486.md) |
| Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows | Hedge funds have significantly increased their short positions against Hims & Hers Health, reaching a peak in January, j | [Link](https://longbridge.com/zh-CN/news/275905695.md) |
| ANALYSIS-US could take action including fines against Hims after brief Wegovy copy launch | The Trump administration may take legal action against Hims for attempting to sell a compounded version of Novo Nordisk’ | [Link](https://longbridge.com/zh-CN/news/275888721.md) |
| Eli Lilly (LLY) Builds $1.5 Billion Inventory of Weight-Loss Pill | Eli Lilly (LLY) has prepared a $1.5 billion inventory of its new weight-loss pill, Orforglipron, ahead of its anticipate | [Link](https://longbridge.com/zh-CN/news/276070062.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。